Abstract

Compounding Naltrexone for the Treatment of Autism

Author(s): Wynn Tom, Brunetti Sarah

Issue: Jul/Aug 2009 - Homone Replacement Therapy

Page(s): 296-299

Download in electronic PDF format for $75

Abstract

Autism is a complex disorder that affects children. Children who present with symptoms of autism require a comprehensive evaluation by a multidisciplinary team including a psychologist, neurologist, psychiatrist, speech therapist, and other professionals who diagnose children with autism spectrum disorders. Following the diagnosis, a treatment plan is developed, which in most cases involve educational and behavioral interventions and medications. The multidisciplinary team then expands to a team of professionals to treat the disorder, the team of which includes a pharmacist. Anxiety, depression, obsessive-compulsive disorder, behavioral problems, seizures, impulsivity, and hyperactivity are the main symptoms of autism that have in many cases been successfully minimized and in some cases alleviated by proper medication.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2009 Pg. 296-299	Compounding Naltrexone for the Treatment of Autism Author(s): Wynn Tom, Brunetti Sarah
Jul/Aug 2018 Pg. 270-278	Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report Author(s): Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
May/Jun 2021 Pg. 233	Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 482-485	Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars Author(s): Harris Kylie, Wright Edward
May/Jun 2013 Pg. 235	Naltrexone Hydrochloride 50-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 157-162	Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Morris Tommy C, Graves Richard A
Jan/Feb 2000 Pg. 17-20	Opioids: A Review of the Pharmacology Author(s): Ford Peter R
Jan/Feb 2001 Pg. 18-19	Autism in Children Author(s): Cave Stephanie
Nov/Dec 2005 Pg. 487-488	PostScription: Compounding Pharmacies and the Successful Treatment of Autism Author(s): Neurander James A
Jul/Aug 2003 Pg. 266-270	Sensitization Therapy for Warts Author(s): Kuntz Rachael
Sep/Oct 2009 Pg. 386-389	Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Author(s): Williams LaVonn A, Fokken Dawn
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Nov/Dec 2005 Pg. 413-420	Unlocking Autism: Is Compounding the Key? Author(s): Vail Jane
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2023 Pg. 468-473	Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management Author(s): Rodriguez Franklin, Carvalho Maria, Banov Fabiana
May/Jun 2016 Pg. 197-201	Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients Author(s): Sturn Kayla M, Collin Michael
Jan/Feb 2023 Pg. 6-10	Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE Author(s): Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew